Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from 3D Medicines, Inc. ( (HK:1244) ).
3D Medicines Inc., incorporated in the Cayman Islands, has announced a board meeting scheduled for March 31, 2025. The meeting will focus on approving the audited annual results for the financial year ending December 31, 2024, and considering the payment of a final dividend. This announcement marks a significant step in the company’s financial operations, potentially impacting its market positioning and stakeholder interests.
More about 3D Medicines, Inc.
YTD Price Performance: 35.06%
Average Trading Volume: 299,210
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$1.07B
See more insights into 1244 stock on TipRanks’ Stock Analysis page.